Quarterly report [Sections 13 or 15(d)]

Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details)

v3.25.1
Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Antidilutive Securities (in shares) 21,697 2,570
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities (in shares) 181 197
Restricted Stock [Member]    
Antidilutive Securities (in shares) 836 1,133
Warrant [Member]    
Antidilutive Securities (in shares) 13,696 1,240
Shares Held in Abeyance [Member]    
Antidilutive Securities (in shares) [1] 6,984 0
[1] Includes the weighted average effect of the Existing Investor Warrant Shares held in abeyance as of March 31, 2025. Refer to Note 11. Capitalization and Equity Structure – Warrants for additional information regarding the Inducement Warrant.